-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
The Group’s new Jiangsu Bosheng product, the “Single-Use Infusion System Multi-Layer Co-Extruded Biomaterial Film,” has entered industrial-scale production and is now being sold.
Category:
发布时间：2021-05-31
Recently, Jiangsu Bosheng Medical New Materials Co., Ltd., a wholly owned subsidiary of Shisi Pharmaceutical Group, has commenced industrial-scale production and sales of its newly developed product—the “Multi-layer Co-extruded Biomedical Film for Single-use Infusion Systems”—making it the only domestic manufacturer currently capable of replacing imported biomedical films.
According to reports, this product complies with United States Pharmacopeia (USP) Class VI standards as well as relevant national standards, and is widely used in the research, development, and manufacturing of vaccines and biopharmaceuticals, boasting significant market growth potential.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code